Indeed, as demonstrated in this study, IFI30 was significantly more expressed in the majority of all cancers than in normal controls, suggesting a critical player in the progression of cancer, as supported by the prognostic and diagnostic value of the KM survival curve and the ROC curve, respectively. The gene discussed is IFI30; the disease is cancer.